Top list · Worldwide
130 autoimmune startups worldwide have raised money in rounds we track. These are the 50 that have raised the most, $8.3B between them, with the United States the most common home.
Candid Therapeutics was a clinical-stage biotechnology company based in San Diego, California, founded in 2024.
Founded 2024San Diego, United States$875Mlast round Mar 2026Dianthus Therapeutics is a biotech company developing new treatments for serious autoimmune diseases using a more targeted approach.
Founded 2019Waltham, United States$719Mlast round Mar 2026Immunovant is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases.
Founded 2018New York, United States$550Mlast round Dec 2025Alumis is a precision medicine company focused on the discovery, development and treatment of autoimmune disorders.
Founded 2021San Francisco, United States$345Mlast round Jan 2026Dice Therapeutics is a clinical-stage biopharmaceutical company that makes medicines for chronic autoimmune and inflammatory diseases.
Founded 2013San Francisco, United States$345Mlast round Oct 2022Viela Bio is a clinical-stage biotechnology company pioneering and advancing treatments for severe inflammation and autoimmune diseases.
Founded 2017United States$325Mlast round Jun 2019Beeline Medicines is a clinical-stage biotechnology company based in Boston, Massachusetts, focused on developing precision therapies for autoimmune and inflamm
Founded 2025Stamford, United States$300Mlast round Apr 2026T-Therapeutics is a next-generation T cell receptor (TCR) company spun off from the University of Cambridge.
Founded 2022Cambridge, United Kingdom$279Mlast round Nov 2026SetPoint Medical is a commercial-stage medical technology company founded in 2007, focused on developing bioelectronic therapies for chronic autoimmune conditions.
Founded 2007Santa Clarita, United States$256Mlast round Aug 2025IGM Biosciences is a biotechnology company that develops medicine for people with infectious infections, autoimmune diseases, and cancer.
Founded -Mountain View, United States$209Mlast round Jun 2023Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.
Founded -Cambridge, United States$200Mlast round Jul 2026Cabaletta Bio has adapted clinically-validated and FDA-approved CAR T cell technology to target B cell-mediated autoimmune diseases.
Founded 2017Philadelphia, PA, United States$200Mlast round May 2026Alpine Immune Sciences is an immunotherapy company focused on developing treatments for autoimmune and inflammatory diseases.
Founded 2015Seattle, United States$199Mlast round Nov 2023Annexon Biosciences is a biotech company, discovering and developing novel therapeutics for neurodegenerative and autoimmune disorders.
Founded -South San Francisco, United States$180Mlast round Jul 2026Timberlyne Therapeutics is a clinical-stage biopharmaceutical company based in San Diego, California, founded in 2024.
Founded -Boerne, United States$180Mlast round Jan 2025Ethyreal Bio is a biotechnology startup developing precision therapies for autoimmune thyroid disorders.
Founded -Cambridge, United States$161Mlast round Jun 2026Kyverna Therapeutics is pioneering a new class of therapies and cures for serious autoimmune diseases.
Founded 2018Berkeley, United States$160Mlast round Dec 2025GentiBio is a clinical-stage biotherapeutics company founded in 2020, focused on developing engineered regulatory T-cell therapies (EngTregs) to address Type 1
Founded 2020Cambridge, United States$157Mlast round Aug 2021Cerulean Pharma develops nanotechnology-based therapeutics for treating oncology, cardiovascular, autoimmune and inflammatory diseases.
Founded 2006San Diego, United States$152Mlast round Apr 2015Zura Bio is a clinical-stage, multi-asset biotechnology company.
Founded 2021Henderson, United States$144Mlast round Feb 2026Alvine Pharmaceuticals is a biotechnology company developing therapeutics for autoimmune and inflammatory diseases.
Founded 2005United States$138Mlast round May 2013Merida Biosciences is a biotechnology company based in Cambridge, Massachusetts, focused on developing precision medicines for autoimmune and allergic diseases.
Founded 2022Cambridge, United States$121Mlast round Apr 2025Elpiscience Biopharmaceuticals is a clinical-stage biopharmaceutical company based in Shanghai, China, founded in 2017.
Founded 2017Shanghai, China$105Mlast round May 2021Synthekine is a biotechnology company based in Menlo Park, California, founded in 2018.
Founded 2018Menlo Park, United States$100Mlast round Jan 2023Maxion Therapeutics is a private biotechnology company based in Cambridge, United Kingdom, founded in 2020.
Founded 2020Cambridge, United Kingdom$91Mlast round Mar 2025Kezar Life Sciences company focused on the discovery and development of drugs targeting protein homeostasis for autoimmune disorders
Founded 2015South San Francisco, United States$85Mlast round Oct 2022AnaptysBio ($ANAB) is a clinical-stage biotechnology company focused on transforming patient health by discovering and developing innovative immunology therapeutics.
Founded 2005San Diego, United States$85Mlast round Jul 2015Celsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients.
Founded 2018Cambridge, United States$83Mlast round Mar 2022RegCell is a biotechnology company founded in 2016 that specializes in developing cell-based immunotherapies focused on regulatory T cells (Tregs).
Founded 2016Emeryville, United States$81Mlast round Sept 2026Zag Bio is a biotechnology company based in Cambridge, Massachusetts, focused on developing thymus-targeted medicines to treat and prevent autoimmune diseases.
Founded 2022Cambridge, United States$80Mlast round Oct 2025Aristea Therapeutics is a developer of novel therapies created for autoimmune diseases.
Founded 2018San Diego, United States$78Mlast round Jul 2021Cue Biopharma is a developer of a productive platform for the treatment of cancer and autoimmune disease.
Founded 2014Cambridge, United States$76Mlast round Jul 2026Connect Biopharma is a developer of novel immune modulators for the treatment of serious autoimmune diseases and inflammation.
Founded 2012China$75Mlast round Jan 2019Shattuck Labs is a biotechnology company that provides novel class biologic medicines for the treatment of cancer and autoimmune disease.
Founded 2016Austin, United States$75Mlast round Jun 2026Lycera discovers and develops small-molecule immunomodulators for the treatment of autoimmune diseases and cancer.
Founded 2006Ann Arbor, United States$75Mlast round Jun 2015Graviton develops novel therapeutics for the treatment of autoimmune, cancer, certain genetic, fibrotic, and other serious diseases.
Founded 2020New York, United States$75Mlast round Feb 2024Arialys Therapeutics is a clinical-stage biotechnology company based in La Jolla, California.
Founded 2022San Diego, United States$73Mlast round Jun 2025ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome.
Founded 2020Cambridge, United States$72Mlast round Sept 2023EXUMA Biotech is a clinical-stage biotechnology company founded in 2015, focused on developing gene vector delivery solutions and CAR-T cell therapies for solid
Founded 2015West Palm Beach, United States$70Mlast round Aug 2026Landos Biopharma is a developer of an oral first-in-class therapeutics designed to target autoimmune diseases.
Founded 2017United States$70Mlast round Aug 2019SciRhom GmbH is a biotechnology company based in Martinsried, Germany, founded in 2016.
Founded 2016Planegg, Germany$68Mlast round Jul 2024Hillstar Bio is a Boston-based biotechnology company founded in 2023, specializing in precision immunology.
Founded 2023Boston, United States$67Mlast round Mar 2025Dualitas Therapeutics is a biotechnology company based in South San Francisco, CA, founded in 2023.
Founded 2023South San Francisco, United States$65Mlast round Sept 2025SuppreMol is a biotechnology company developing treatment of autoimmune diseases leading to the cure of such disorders.
Founded 2002Martinsried, Germany$63Mlast round May 2013Oblenio Bio is a biotechnology company that develops T-cell engager therapeutic candidates for autoimmune disease treatment.
Founded -Oakland, United States$62Mlast round Jun 2026Virdante Pharmaceuticals is a biopharmaceutical company developing and commercializing drugs for autoimmune and inflammatory diseases.
Founded 2007United States$60Mlast round Oct 2011Immunitas Therapeutics is a clinical-stage biopharmaceutical company founded in 2019, focused on discovering and developing novel antibody-based therapeutics fo
Founded 2019Waltham, United States$58Mlast round Aug 2021Trubion Pharmaceuticals is a biopharmaceutical company creating a pipeline of product candidates to treat autoimmune disease and cancer.
Founded 1999United States$56Mlast round Sept 2009InnoCare is a Chinese biopharmaceutical company that develops treatment for cancer and autoimmune diseases.
Founded -China$55Mlast round Feb 2021Appia Bio was a biotechnology company founded in 2020 and based in Culver City, California.
Founded 2020Los Angeles, United States$52Mlast round May 2021Companies whose own description names this theme, ranked by the total they have raised in rounds we hold. Nobody pays to be on a list.
Open any company for its rounds and investors, or search the investors who back autoimmune startups worldwide in the app, with filters, lists and exports.
GV
V
RPHealth startups worldwide12,811 companies · $81B
O
A
XAI startups worldwide10,238 companies · $830B
GV
V
RPBiotech startups worldwide7,127 companies · $70B
D
B
FTBig data startups worldwide3,812 companies · $220BAF
R
SFintech startups worldwide3,200 companies · $94B
O
A
BAI startups that raised in 20262,922 companies · $540B in 2026
FT
CE
PEnergy providers startups worldwide2,808 companies · $152B
P
OMarketing tech startups worldwide2,728 companies · $28B